SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-023542
Filing Date
2022-02-15
Accepted
2022-02-15 09:05:38
Documents
16
Period of Report
2022-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226786d1_8k.htm   iXBRL 8-K 29409
2 EXHIBIT 1.1 tm226786d1_ex1-1.htm EX-1.1 238883
3 EXHIBIT 5.1 tm226786d1_ex5-1.htm EX-5.1 11136
7 GRAPHIC tm226786s1_ex5-1img01.jpg GRAPHIC 3110
8 GRAPHIC tm226786s1_ex5-1img02.jpg GRAPHIC 2857
  Complete submission text file 0001104659-22-023542.txt   520343

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA twst-20220210.xsd EX-101.SCH 3054
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20220210_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20220210_pre.xml EX-101.PRE 22609
10 EXTRACTED XBRL INSTANCE DOCUMENT tm226786d1_8k_htm.xml XML 3479
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

IRS No.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 22637208
SIC: 2836 Biological Products, (No Diagnostic Substances)